top of page

Tanner Stages and Puberty Blockers: How Puberty Is Staged Before Care Is Considered

TransHealthHub
Oct 8
4 min read

Key Takeaways

  • How do Tanner stages relate to puberty blockers? The Endocrine Society's 2017 guideline says puberty-pausing medication is considered after a clinician confirms puberty has started, defined as Tanner stage 2 or higher.

  • Cleveland Clinic describes Tanner stages as a five-stage classification system for physical changes of puberty and a general guide rather than a strict timeline.

  • Cleveland Clinic lists stage 2 as typically ages 8 to 13 for girls and 9 to 14 for boys.

  • A 2020 study at four U.S. gender centers of 63 early-pubertal youth found 63.5% at Tanner stage 2 and 36.5% at stage 3.


The short answer

Puberty blockers are considered only after a clinician confirms that puberty has begun, which the Endocrine Society's 2017 guideline defines as Tanner stage 2 or higher. Tanner stages are a five-stage scale that tracks physical development, so the stage tells a care team how far puberty has progressed, not how old a young person is.


You may see this medication called puberty blockers, GnRH (gonadotropin-releasing hormone) analogs, or puberty-pausing medication. The terms describe the same treatment, and this page uses "puberty-pausing medication" for most of the text.


At TransHealthHub, we pulled these details from clinical sources. Our subpage on how long puberty-pausing medication is used covers the timing question that often comes next.


What each stage describes

Tanner stage

What Cleveland Clinic describes

Endocrine Society position

Stage 1

Prepubertal, with no visible changes yet

Not recommended before puberty starts

Stage 2, girls

Typically ages 8 to 13; first visible breast changes

Care can be considered once a clinician confirms

Stage 2, boys

Typically ages 9 to 14; first visible genital growth

Care can be considered once a clinician confirms


Why stage 2 is the starting point

The Endocrine Society's 2017 guideline says clinicians should begin puberty-pausing medication after girls and boys first show physical changes of puberty. Its eligibility table calls for a pediatric endocrinologist or other experienced clinician to confirm puberty has started, written as Tanner stage 2 or higher. The guideline does not recommend it for prepubertal children.



The guideline rates the evidence behind its recommendation to use these medications as low quality, a limitation the Endocrine Society states itself.


How a clinician confirms the stage

The Endocrine Society's patient guidance says care could be considered once an experienced clinician confirms the start of puberty. It lists a physical exam or lab analysis as ways to confirm this, and says a qualified mental health provider must also confirm gender dysphoria.


Oregon Health & Science University (OHSU) Doernbecher says medical treatment usually does not begin until puberty, and that a first visit may include a physical exam and blood test to see how far puberty has progressed. Our guide to how teens are assessed covers the evaluation alongside it.


What research says about young people at stages 2 and 3

A 2020 Journal of the Endocrine Society study assessed 63 early-pubertal transgender and gender-diverse youth, 33 assigned male at birth and 30 assigned female, at four U.S. pediatric gender centers. Bone density was measured before treatment or within two months of starting it. Before treatment, average bone density scores were below the population reference average in both groups, except at the hip in the assigned-female group.


The authors compared participants with population reference standards, not a matched control group, and the measurements came before treatment. The result describes these youth at the start of care and is not an effect of the medication. The authors suggested low calcium intake and reduced physical activity may partly explain this.


A 2024 Journal of Adolescent Health study of 438 youth included 40 who were prescribed puberty-pausing medication at Tanner stage 2 or 3. In this cross-sectional comparison at a hormone-readiness evaluation, that group reported less anxiety, depression, and stress than peers who had not received it. The two groups differed in age, sex assigned at birth, gender identity, and race and ethnicity, so the finding is an association and does not prove a treatment effect.


What U.S. medical societies say

The American Medical Association, American Academy of Pediatrics, American Psychological Association, and the Endocrine Society regard this care as evidence-based and medically necessary, and oppose government interference in these decisions.


The American Medical Association said in April 2021 that decisions about medical care belong within the patient-physician relationship.


Where care is available

The Kaiser Family Foundation's (KFF) policy tracker, updated September 29, 2026, reports that 27 states have enacted laws or policies limiting youth access to this care.


Frequently asked questions

Can puberty-pausing medication start before puberty begins? The Endocrine Society's 2017 guideline does not recommend it for prepubertal children, and Mayo Clinic says it is not recommended for children who have not started puberty.

Who confirms a Tanner stage? The guideline says a pediatric endocrinologist or experienced clinician does.

Does everyone reach each stage at the same age? Cleveland Clinic says the stages are a general guide and not a strict timeline. Families asking about puberty blockers for a specific young person can raise it with that young person's clinician.


Further Reading and Resources


This page addresses a health topic and reflects the evidence as of October 2026. It is not medical advice. Decisions about a young person's care belong to that young person, their family, and their clinicians.

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
  • Youtube
  • X
  • Facebook
  • Instagram

If you are in crisis or thinking about suicide, help is available right now.

Call or text 988 (the 988 Suicide & Crisis Lifeline).

​​​​​

© 2026 TransHealthHub

bottom of page